Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.

RCUS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 12.30%

Insider Buying (Last 12 Months): $339,452,595.00

Insider Selling (Last 12 Months): $3,417,282.87

Arcus Biosciences Insider Trading History Chart

Arcus Biosciences Share Price & Price History

^$15.24

▼ -0.32 (-2.06%)

As of 05/8/2024 01:00 AM ET

Days: 30 | 90 | 365

The new financial threat that could wipe out millions…

From InvestorPlace | Ad

During the Internet boom, companies like Pets.com were supposed to be promising investments riding the wave of a new tech boom. But then they were gone within a blink of an eye. One of the most successful investors in history just stepped forward to say the same thing is about to happen to AI stocks.

Pay close attention to this important video

Arcus Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/27/2024	Jennifer Jarrett	COO	Sell	11,551	$17.55	$202,720.05	215,253
3/18/2024	Jennifer Jarrett	COO	Sell	13,449	$17.92	$241,006.08	226,804
2/26/2024	Jennifer Jarrett	COO	Sell	24,555	$20.07	$492,818.85	274,323
2/26/2024	Juan C. Jaen	President	Sell	3,900	$20.06	$78,234.00	1,211,365
1/29/2024	Gilead Sciences, Inc.	Major Shareholder	Buy	15,238,095	$21.00	$319,999,995.00	30,061,124
1/2/2024	Juan C. Jaen	President	Sell	6,975	$20.09	$140,127.75	1,215,265
1/2/2024	Robert C Goeltz II	CFO	Sell	2,004	$20.00	$40,080.00	51,831
12/22/2023	Jennifer Jarrett	COO	Sell	21,521	$17.76	$382,212.96	258,878
9/22/2023	Jennifer Jarrett	COO	Sell	21,369	$19.99	$427,166.31	302,691
7/28/2023	Jennifer Jarrett	COO	Sell	45,000	$20.25	$911,250.00	336,566
7/3/2023	Alexander Azoy	CAO	Sell	1,018	$20.41	$20,777.38	11,596
6/28/2023	Gilead Sciences, Inc.	Major Shareholder	Buy	1,010,000	$19.26	$19,452,600.00	14,823,029
6/22/2023	Jennifer Jarrett	COO	Sell	12,437	$19.12	$237,795.44	381,566
6/16/2023	Jennifer Jarrett	COO	Sell	12,563	$19.35	$243,094.05	394,003
3/16/2023	Jennifer Jarrett	COO	Sell	8,729	$16.81	$146,734.49	406,217
1/26/2023	Jennifer Jarrett	COO	Sell	300	$23.56	$7,068.00	416,546
12/16/2022	Carolyn C Tang	General Counsel	Sell	2,523	$30.75	$77,582.25	28,584
12/16/2022	Jennifer Jarrett	COO	Sell	16,482	$30.75	$506,821.50	147,609
12/16/2022	Juan C. Jaen	President	Sell	4,436	$30.75	$136,407.00	218,258
12/16/2022	Robert C Goeltz II	CFO	Sell	2,453	$30.75	$75,429.75	11,566
12/16/2022	Terry J. Rosen	CEO	Sell	13,043	$30.75	$401,072.25	242,173
9/16/2022	Jennifer Jarrett	COO	Sell	12,677	$26.28	$333,151.56	130,942
6/16/2022	Carolyn C Tang	General Counsel	Sell	1,400	$20.72	$29,008.00	25,431
6/16/2022	Jennifer Jarrett	COO	Sell	6,081	$20.72	$125,998.32	125,233
6/16/2022	Juan C. Jaen	President	Sell	2,333	$20.72	$48,339.76	212,574
6/16/2022	Terry J. Rosen	CEO	Sell	4,241	$20.72	$87,873.52	232,329
3/16/2022	Jennifer Jarrett	COO	Sell	9,617	$31.62	$304,089.54
12/20/2021	Jennifer Jarrett	COO	Sell	34,822	$41.48	$1,444,416.56
12/16/2021	Carolyn C Tang	General Counsel	Sell	487	$39.82	$19,392.34
12/16/2021	Jennifer Jarrett	COO	Sell	5,560	$39.82	$221,399.20
12/16/2021	Juan C. Jaen	President	Sell	865	$39.82	$34,444.30
12/16/2021	Robert C Goeltz II	CFO	Sell	485	$39.83	$19,317.55
12/16/2021	Terry J. Rosen	CEO	Sell	2,299	$39.82	$91,546.18
9/20/2021	Jennifer Jarrett	COO	Sell	30,634	$35.18	$1,077,704.12
6/16/2021	Carolyn C. Tang	General Counsel	Sell	1,309	$24.16	$31,625.44
6/4/2021	Jennifer Jarrett	COO	Sell	1,044	$24.91	$26,006.04

Tech GIANT’s Plans to Revolutionize Crypto…

From Crypto 101 Media | Ad

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

SEC Filings (Institutional Ownership Changes) for Arcus Biosciences (NYSE:RCUS)

92.89% of Arcus Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Arcus Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/8/2024	BNP PARIBAS ASSET MANAGEMENT Holding S.A.	685,025	$12.93M	0.0%	+26.9%	0.753%
5/8/2024	ProShare Advisors LLC	10,846	$0.21M	0.0%	+7.4%	0.012%
5/8/2024	Headlands Technologies LLC	3,139	$59K	0.0%	N/A	0.003%
5/7/2024	SG Americas Securities LLC	8,642	$0.16M	0.0%	-58.0%	0.010%
5/2/2024	Nordea Investment Management AB	259,372	$4.89M	0.0%	+26.3%	0.285%
5/1/2024	BNP Paribas Financial Markets	35,640	$0.67M	0.0%	-67.7%	0.039%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	32,356	$0.58M	0.0%	+5.6%	0.036%
4/30/2024	Allspring Global Investments Holdings LLC	12,940	$0.24M	0.0%	+9.2%	0.014%
4/29/2024	Principal Financial Group Inc.	289,965	$5.48M	0.0%	-12.9%	0.319%
4/26/2024	Yousif Capital Management LLC	24,639	$0.47M	0.0%	-9.1%	0.027%
4/24/2024	Assenagon Asset Management S.A.	39,731	$0.75M	0.0%	-15.9%	0.044%
4/23/2024	Spartan Fund Management Inc.	2,000	$38K	0.1%	N/A	0.002%
4/18/2024	Allspring Global Investments Holdings LLC	12,940	$0.24M	0.0%	+9.2%	0.014%
4/18/2024	Diversified Trust Co	12,078	$0.23M	0.0%	N/A	0.013%
4/5/2024	GAMMA Investing LLC	2,427	$46K	0.0%	+51.6%	0.003%
3/22/2024	PNC Financial Services Group Inc.	1,507	$29K	0.0%	-61.4%	0.002%
3/11/2024	Vanguard Group Inc.	4,680,716	$89.40M	0.0%	+4.2%	5.152%
2/15/2024	Octagon Capital Advisors LP	1,868,000	$35.68M	5.7%	-5.1%	2.495%
2/15/2024	Parkman Healthcare Partners LLC	247,664	$4.73M	0.7%	+20.7%	0.331%
2/14/2024	Pennant Investors LP	23,700	$0.45M	0.1%	N/A	0.032%
2/14/2024	Sectoral Asset Management Inc.	97,435	$1.86M	0.8%	-74.0%	0.130%
2/13/2024	Tower Research Capital LLC TRC	2,514	$48K	0.0%	-47.4%	0.003%
2/13/2024	Rafferty Asset Management LLC	251,404	$4.80M	0.0%	-14.1%	0.336%
2/13/2024	NEOS Investment Management LLC	11,141	$0.21M	0.0%	N/A	0.015%
2/13/2024	Campbell & CO Investment Adviser LLC	62,894	$1.20M	0.1%	N/A	0.084%
2/12/2024	Alpha DNA Investment Management LLC	28,690	$0.55M	0.2%	+11.6%	0.038%
2/12/2024	Capstone Investment Advisors LLC	10,643	$0.20M	0.0%	N/A	0.014%
2/12/2024	Decheng Capital LLC	869,790	$16.61M	4.6%	N/A	1.162%
2/12/2024	Cape Investment Advisory Inc.	4,045	$77K	0.0%	N/A	0.005%
2/9/2024	Quest Partners LLC	4,013	$77K	0.0%	N/A	0.005%
2/9/2024	Trexquant Investment LP	43,537	$0.83M	0.0%	-44.6%	0.058%
2/8/2024	Panagora Asset Management Inc.	228,996	$4.37M	0.0%	+130.6%	0.306%
2/8/2024	Massachusetts Financial Services Co. MA	56,346	$1.08M	0.0%	-3.1%	0.075%
2/7/2024	Principal Financial Group Inc.	332,814	$6.36M	0.0%	+1.0%	0.445%
2/7/2024	Dimensional Fund Advisors LP	1,594,609	$30.46M	0.0%	+11.0%	2.130%
2/7/2024	BNP Paribas Financial Markets	110,366	$2.11M	0.0%	+32.5%	0.147%
2/7/2024	Teacher Retirement System of Texas	11,155	$0.21M	0.0%	-17.3%	0.015%
2/7/2024	E Fund Management Co. Ltd.	13,501	$0.26M	0.0%	-10.2%	0.018%
2/6/2024	Charles Schwab Investment Management Inc.	472,182	$9.02M	0.0%	+2.5%	0.631%
2/6/2024	Amalgamated Bank	21,027	$0.40M	0.0%	-4.4%	0.028%
2/6/2024	Swiss National Bank	95,396	$1.82M	0.0%	-8.6%	0.127%
2/5/2024	Victory Capital Management Inc.	104,413	$1.99M	0.0%	+53.3%	0.139%
2/5/2024	Mach 1 Financial Group LLC	25,314	$0.48M	0.2%	+11.2%	0.034%
2/1/2024	Yousif Capital Management LLC	27,094	$0.52M	0.0%	-5.6%	0.036%
2/1/2024	GAMMA Investing LLC	1,601	$31K	0.0%	N/A	0.002%
2/1/2024	Handelsbanken Fonder AB	12,800	$0.24M	0.0%	N/A	0.017%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	18,883	$0.36M	0.0%	+37.5%	0.025%
1/30/2024	Strs Ohio	8,300	$0.16M	0.0%	+245.8%	0.011%
1/29/2024	Louisiana State Employees Retirement System	27,000	$0.52M	0.0%	N/A	0.036%
1/25/2024	Allspring Global Investments Holdings LLC	11,850	$0.23M	0.0%	+27.0%	0.016%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	30,654	$0.59M	0.0%	-2.7%	0.041%
1/17/2024	Assenagon Asset Management S.A.	47,253	$0.90M	0.0%	N/A	0.063%
1/12/2024	SG Americas Securities LLC	20,568	$0.39M	0.0%	N/A	0.027%
1/10/2024	Nordea Investment Management AB	205,428	$3.95M	0.0%	-3.0%	0.274%
1/5/2024	Exchange Traded Concepts LLC	6,816	$0.13M	0.0%	+34.0%	0.009%
12/19/2023	Public Employees Retirement System of Ohio	2,000	$36K	0.0%	N/A	0.003%
12/18/2023	Vanguard Group Inc.	4,493,818	$80.66M	0.0%	+1.4%	6.003%
12/7/2023	Hudson Bay Capital Management LP	80,000	$1.44M	0.0%	-30.4%	0.107%
11/30/2023	American Century Companies Inc.	457,695	$8.22M	0.0%	+3.0%	0.611%
11/15/2023	Sectoral Asset Management Inc.	375,456	$6.74M	1.3%	+5.9%	0.502%
11/15/2023	Seven Eight Capital LP	16,265	$0.29M	0.0%	N/A	0.022%
11/15/2023	Alps Advisors Inc.	54,951	$0.99M	0.0%	+2.3%	0.073%
11/14/2023	Schonfeld Strategic Advisors LLC	142,900	$2.57M	0.0%	-21.9%	0.191%
11/14/2023	Trexquant Investment LP	78,637	$1.41M	0.0%	N/A	0.105%
11/14/2023	Profund Advisors LLC	51,071	$0.92M	0.1%	-9.4%	0.068%
11/13/2023	Algert Global LLC	72,018	$1.29M	0.1%	+15.8%	0.096%
11/13/2023	Dark Forest Capital Management LP	38,224	$0.69M	0.1%	N/A	0.051%
11/13/2023	FMR LLC	4,780,052	$85.80M	0.0%	+4.9%	6.385%
11/13/2023	Nordea Investment Management AB	211,784	$3.79M	0.0%	+12.9%	0.283%
11/13/2023	Rafferty Asset Management LLC	292,708	$5.25M	0.0%	-2.5%	0.391%
11/13/2023	E Fund Management Co. Ltd.	15,038	$0.27M	0.0%	-6.8%	0.020%
11/9/2023	Rhumbline Advisers	169,849	$3.05M	0.0%	+2.5%	0.228%
11/9/2023	Deutsche Bank AG	26,854	$0.48M	0.0%	+14.4%	0.036%
11/9/2023	Citigroup Inc.	145,729	$2.62M	0.0%	+20.8%	0.196%
11/9/2023	Commonwealth of Pennsylvania Public School Empls Retrmt SYS	35,863	$0.64M	0.0%	-39.7%	0.048%
11/9/2023	Texas Permanent School Fund Corp	45,538	$0.82M	0.0%	-1.7%	0.061%
11/8/2023	Charles Schwab Investment Management Inc.	460,841	$8.27M	0.0%	+5.5%	0.619%
11/8/2023	Massachusetts Financial Services Co. MA	58,126	$1.04M	0.0%	-3.7%	0.078%
11/8/2023	Swiss National Bank	104,396	$1.87M	0.0%	+9.5%	0.140%
11/8/2023	New York Life Investment Management LLC	19,520	$0.35M	0.0%	-13.6%	0.026%
11/7/2023	Alpha DNA Investment Management LLC	25,716	$0.46M	0.2%	N/A	0.035%
11/7/2023	New York State Common Retirement Fund	20,856	$0.37M	0.0%	-42.2%	0.028%
11/7/2023	Barclays PLC	470,776	$8.45M	0.0%	+183.4%	0.632%
11/7/2023	Fox Run Management L.L.C.	19,826	$0.36M	0.1%	N/A	0.027%
11/7/2023	Arizona State Retirement System	13,530	$0.24M	0.0%	+10.0%	0.018%
11/6/2023	Illinois Municipal Retirement Fund	27,547	$0.49M	0.0%	N/A	0.037%
11/6/2023	Victory Capital Management Inc.	68,101	$1.22M	0.0%	-8.2%	0.091%
11/3/2023	Platinum Investment Management Ltd.	204,398	$3.67M	0.1%	-12.1%	0.274%
11/2/2023	Principal Financial Group Inc.	329,442	$5.91M	0.0%	+0.4%	0.442%
10/31/2023	Teacher Retirement System of Texas	13,496	$0.24M	0.0%	+13.6%	0.018%
10/31/2023	Panagora Asset Management Inc.	99,299	$1.78M	0.0%	+2.2%	0.133%
10/30/2023	Yousif Capital Management LLC	28,699	$0.52M	0.0%	-3.7%	0.039%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	31,509	$0.57M	0.0%	-2.6%	0.042%
10/26/2023	Strs Ohio	2,400	$43K	0.0%	N/A	0.003%
10/25/2023	BluePath Capital Management LLC	1,568	$28K	0.0%	N/A	0.002%
10/25/2023	Zurcher Kantonalbank Zurich Cantonalbank	13,732	$0.25M	0.0%	+20.0%	0.018%
10/24/2023	Bank of New York Mellon Corp	448,582	$8.05M	0.0%	-2.5%	0.602%
10/24/2023	Maryland State Retirement & Pension System	19,758	$0.36M	0.0%	-3.7%	0.027%
10/18/2023	Exchange Traded Concepts LLC	5,087	$91K	0.0%	-27.1%	0.007%
10/17/2023	Mach 1 Financial Group LLC	22,774	$0.41M	0.2%	N/A	0.031%

Data available starting January 2016

Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. The company's pipeline products include Domvanalimab, an anti-TIGIT antibody, which is in Phase 2 and Phase 3 clinical trial; and AB308, an investigational anti-TIGIT monoclonal antibody, which is in Phase 1b clinical trial to study people with advanced solid and hematologic malignancies. It also develops Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in Phase 2 clinical trial; Quemliclustat, a small-molecule CD73 inhibitor, which is Phase 1b and Phase 2 clinical trial; Zimberelimab, an anti-PD-1 antibody, which is in Phase 2 clinical trial for metastatic cell lung cancer and monotherapy; and AB521, an oral and small-molecule inhibitor of HIF-2a, which is in Phase 1 clinical trial for the treatment of Von Hippel-Lindau disease. In addition, the company's preclinical pipeline products include AB598, a CD39 antibody; and AB801, a small molecule Axl inhibitor. It has a clinical collaboration with AstraZeneca to evaluate domvanalimab in combination with durvalumab in a registrational phase 3 clinical trial in patients with unresectable Stage 3 NSCLC; and BVF Partners L.P. to support the discovery and development of compounds for the treatment of inflammatory diseases. Arcus Biosciences, Inc. was incorporated in 2015 and is headquartered in Hayward, California.

Today's Range

Now: $15.24

$15.04

$15.56

50 Day Range

MA: $17.01

$14.59

$19.36

52 Week Range

Now: $15.24

$12.95

$25.47

Volume

505,282 shs

Average Volume

771,717 shs

Market Capitalization

$1.39 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.91

Who are the company insiders with the largest holdings of Arcus Biosciences?: Arcus Biosciences' top insider shareholders include:
Gilead Sciences, Inc (Major Shareholder)
Juan C Jaen (President)
Jennifer Jarrett (COO)
Terry J Rosen (CEO)
Robert C Goeltz II (CFO)
Carolyn C Tang (General Counsel)
Alexander Azoy (CAO)
Learn More about top insider investors at Arcus Biosciences.
Who are the major institutional investors of Arcus Biosciences?: Arcus Biosciences' top institutional shareholders include:
BNP PARIBAS ASSET MANAGEMENT Holding S.A. — 0.75%
Principal Financial Group Inc. — 0.32%
Nordea Investment Management AB — 0.29%
Assenagon Asset Management S.A. — 0.04%
BNP Paribas Financial Markets — 0.04%
Mirae Asset Global Investments Co. Ltd. — 0.04%
Learn More about top institutional investors of Arcus Biosciences stock.
Which major investors are selling Arcus Biosciences stock?: In the previous quarter, RCUS stock was sold by these institutional investors:
BNP Paribas Financial Markets
Simplex Trading LLC
Principal Financial Group Inc.
SG Americas Securities LLC
Assenagon Asset Management S.A.
Yousif Capital Management LLC
Within the previous year, company insiders that have sold Arcus Biosciences company stock include:
Gilead Sciences, Inc (Major Shareholder)
Juan C Jaen (President)
Jennifer Jarrett (COO)
Terry J Rosen (CEO)
Learn More investors selling Arcus Biosciences stock.
Which major investors are buying Arcus Biosciences stock?: During the previous quarter, RCUS stock was bought by institutional investors including:
BNP PARIBAS ASSET MANAGEMENT Holding S.A.
Nordea Investment Management AB
Diversified Trust Co
Headlands Technologies LLC
Spartan Fund Management Inc.
Mirae Asset Global Investments Co. Ltd.
Allspring Global Investments Holdings LLC
Allspring Global Investments Holdings LLC

Elon Musk Secret Crypto Plot Exposed